Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Change in Taxes (2016 - 2020)

Tvardi Therapeutics' Change in Taxes history spans 8 years, with the latest figure at $255000.0 for Q4 2020.

  • On a quarterly basis, Change in Taxes changed N/A to $255000.0 in Q4 2020 year-over-year; TTM through Dec 2024 was $255000.0, a N/A change, with the full-year FY2024 number at -$697000.0, changed N/A from a year prior.
  • Change in Taxes hit $255000.0 in Q4 2020 for Tvardi Therapeutics, up from $132000.0 in the prior quarter.
  • Over the last five years, Change in Taxes for TVRD hit a ceiling of $369000.0 in Q3 2019 and a floor of -$304000.0 in Q2 2018.
  • Historically, Change in Taxes has averaged $91842.1 across 5 years, with a median of $122000.0 in 2020.
  • Biggest five-year swings in Change in Taxes: soared 866.67% in 2016 and later tumbled 15300.0% in 2018.
  • Tracing TVRD's Change in Taxes over 5 years: stood at $189000.0 in 2016, then crashed by 86.24% to $26000.0 in 2017, then soared by 380.77% to $125000.0 in 2018, then skyrocketed by 195.2% to $369000.0 in 2019, then crashed by 30.89% to $255000.0 in 2020.
  • Business Quant data shows Change in Taxes for TVRD at $255000.0 in Q4 2020, $132000.0 in Q3 2020, and $182000.0 in Q2 2020.